<DOC>
	<DOCNO>NCT01166997</DOCNO>
	<brief_summary>The ULTIMA study intend prove patient pulmonary embolism right ventricular end diastolic diameter leave ventricular end diastolic diameter ratio ≥1 ( RV/LV ratio ) benefit treatment ultrasound accelerate thrombolysis ( rt-PA ) compare unfractionated heparin anticoagulation . Specifically , 24 hour RV/LV ratio significantly reduce treatment arm compare control arm .</brief_summary>
	<brief_title>ULTrasound Accelerated ThrombolysIs PulMonAry Embolism</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Patients acute PE symptom &lt; 14 day . Filling defect contrastenhanced chest CT least one main proximal lower lobe pulmonary artery Right ventricular dysfunction confirm echocardiography RV/LV end diastolic diameter ratio ≥ 1.0 . Age le 18 year great 80 year Index PE symptom duration &gt; 14 day Insufficient echocardiographic image quality apical subcostal fourchamber view prohibit measurement right leave ventricular enddiastolic dimension Known significant bleeding risk Administration thrombolytic agent , e.g. , tissue plasminogen activator , streptokinase , urokinase , within previous 4 day Active bleed Known bleed diathesis Known coagulation disorder , platelet count &lt; 100 000/mm3 , previous use vitamin K antagonists INR &gt; 2.5 History intracranial intraspinal surgery trauma intracranial/intraspinal bleed Intracranial neoplasm , arteriovenous malformation , aneurysm Recent ( &lt; 3 month ) GI bleeding . Recent ( &lt; 3 month ) internal eye surgery hemorrhagic retinopathy ; recent ( &lt; 10 day ) major surgery , cataract surgery , trauma , CPR , obstetrical delivery , invasive procedure . Allergy , hypersensitivity , thrombocytopenia heparin , rtPA , iodinate contrast , except mildmoderate contrast allergy steroid premedication use . Estimated glomerular filtration rate ( eGFR ) &lt; 50 ml/min calculate Cockroft formula . Hemodynamic collapse presentation define : need cardiopulmonary resuscitation ; systolic blood pressure &lt; 90 mm Hg least 15 min , drop systolic blood pressure least 40 mm Hg least 15 min sign end organ hypoperfusion ( cold extremity low urinary output &lt; 30 mL/h mental confusion ) ; need catecholamine administration maintain adequate organ perfusion systolic blood pressure &gt; 90 mm Hg . Severe hypertension repeat reading ( systolic &gt; 180 mmHg diastolic &gt; 105 mmHg ) . Pregnant , lactation parturition within previous 30 day ( positive pregnancy test , woman childbearing age must test ) . Participating investigational drug device study . Life expectancy &lt; 90 day . Inability comply study assessment ( e.g . due geographic distance ) . Previous enrollment study Any condition investigator feel would place patient increase risk investigational therapy initiate . Known righttoleft shunt , example large patent foramen ovale atrial septal defect Large ( &gt; 10 mm ) right atrial right ventricular thrombus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pulmonary embolism</keyword>
	<keyword>Pulmonary thromboembolism</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>ultrasound accelerate thrombolysis</keyword>
</DOC>